News Realcan Pharmaceutical Group Co., Ltd.

Equities

002589

CNE1000013X5

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
2.68 ^CNY	0.00%		+11.67%	-18.04%

Apr. 29	Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Realcan Pharmaceutical Group Co., Ltd.(XSEC:002589) added to S&P Global BMI Index	23-09-18	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Realcan Pharmaceutical Group Co., Ltd. Approves the Executive Appointments	23-05-22	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Shanghai Pharmaceutical Co., Ltd. entered into an agreement to acquire 51% stake in Hunan Runji Pharmaceutical Co., Ltd. from Realcan Pharmaceutical Group Co., Ltd. for CNY 149 million	23-01-16	CI
Realcan Pharmaceutical Group Co., Ltd. agreed to acquire 9.6409% of Shandong Lekang Jinyue Industrial Co., Ltd. from Yantai Chenghou Investment Co., Ltd for CNY 84.84 million.	22-12-15	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Realcan Pharmaceutical Group Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 22, 2022	22-07-14	CI
Realcan Pharmaceutical Group Co., Ltd.(XSEC:002589) dropped from S&P Global BMI Index	22-06-20	CI
Realcan Pharmaceutical Group Co., Ltd. Approves Cash Dividend for the Year 2021	22-05-24	CI
Realcan Pharmaceutical Group Co., Ltd. Announces Profit Distribution Proposal for 2021	22-05-05	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Realcan Pharmaceutical Group Co., Ltd. agreed to acquire a 38.39992% stake in Tianjin Guohui Big Health Technology Co., Ltd. from Yantai Huishuo Enterprise Management Partnership Enterprise for approximately CNY 230 million.	22-02-17	CI
Realcan Pharmaceutical Group Co., Ltd. acquired Health Technology for approximately CNY 230 million.	22-02-16	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Realcan Pharmaceutical Group Co., Ltd.(XSEC:002589) dropped from FTSE All-World Index	21-09-20	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Realcan Pharmaceutical Group Co., Ltd.

Equities

002589

CNE1000013X5

Summary

Filters